Each year in December, ASH Annual Meeting and Exposition brings hematologists from all over the world together, creating a forum to discuss and share critical issues in hematology today. This will be my first attendance to the American Society of Hematology 57th Annual Meeting and Exposition. I’ve been told that nearly 25,000 clinicians, doctors, scientists, researchers, health-care workers, and patients from all over world attend. I’m anxious to hear about all the current and upcoming methods of treatment for multiple myeloma. And possibly meet some of the doctors that are working diligently to cure this disease. I look forward to researching and learning as much as I can. One of my goals will be to learn a little more about the psychological effects of post-treatment and post-therapy for multiple myeloma patients.
Because this is my first time attending an ASH annual conference, I have been researching and taking notes on the selected abstracts and oral presentations to gain a base familiarity with some key terms. I have a notepad filled with FAQs I receive from my support group members, which I will be asking if given the opportunity. I also follow ASH on Twitter and frequently check their website to stay up to date on live events and medical publications.
Attending ASH this year will be a wonderful experience for me: I’m excited and grateful to be given this opportunity! Meeting and hearing doctors from all over the world discuss breakthrough treatments, approved and future drugs for myeloma excites me. I look forward to sharing these experiences with you each day through my Twitter (@IMFprattMYELOMA) and Facebook.
Follow Carlene on Twitter: @IMFprattMYELOMA
The Upland CA Multiple Myeloma Support Group